Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02249819 · ClinicalTrials.gov registry record · Phase 1
Evaluating Anodal tDCS Preceding Aphasia Therapy
A Phase 1 study, sponsored by Northwell Health.
- Terminated
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT02249819 is a Phase 1 study that was terminated before completion, run by Northwell Health. The registered enrollment target is 15 participants.
The verdict
NCT02249819, a Phase 1 study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if non-invasive brain stimulation (transcranial direct current stimulation) delivered prior to language therapy will improve word-finding in individuals with aphasia who are 6 months or greater post-stroke.
Interventions
- DEVICE transcranial direct current stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02249819
The ClinicalTrials.gov registry entry for NCT02249819 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which transcranial direct current stimulation is the first listed.
NCT02249819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02249819 about?
NCT02249819 is a clinical study titled "Evaluating Anodal tDCS Preceding Aphasia Therapy". The purpose of this study is to determine if non-invasive brain stimulation (transcranial direct current stimulation) delivered prior to language therapy will improve word-finding in individuals with aphasia who are 6 months or greater post-stroke.
What is the current status of trial NCT02249819?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2014-09. Estimated completion is 2017-11.
What interventions are being tested in trial NCT02249819?
The interventions under investigation include: transcranial direct current stimulation (DEVICE).
Who is sponsoring clinical trial NCT02249819?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.